Abstract
Aim
To investigate the influence of nonsurgical periodontal treatment (NSPT) on clinical periodontal status, rheumatoid arthritis (RA) activity, and plasmatic and salivary levels of biomarkers through a controlled clinical trial on individuals with RA and periodontitis (PE).
Methods
Sixty-six individuals from a convenience sample were considered eligible and consecutively allocated in 3 groups: (1) individuals without PE and RA (-PE-RA, n = 19); (2) individuals without PE and with RA (-PE+RA, n = 23), and (3) individuals with PE and RA (+PE+RA, n = 24). Full-mouth periodontal clinical examinations, Disease Activity Score (DAS-28) evaluations, and analysis in plasma and saliva of RANKL, OPG, RANKL/OPG, and Survivin were performed at baseline (T1) and 45 days after NSPT (T2).
Results
NSPT in the +PE+RA group was very effective to improve periodontal condition. At T2, significant reductions in DAS-28 were observed in +PE+RA (p = 0.011). Significantly higher levels of Survivin and RANKL were observed in saliva and plasma from RA individuals (with and without PE) compared to controls. Additionally, Survivin e RANKL demonstrated positive correlations with DAS-28 and an expressively significant reduction in +PE+RA at T2 (p < 0.001).
Conclusions
NSPT was effective on improving both the periodontal and the RA clinical status and reducing the concentration of Survivin and RANKL in saliva and plasma.
Practical implications
Nonsurgical periodontal treatment was effective on reducing the concentration of Survivin and RANKL and on improving both the periodontal and the RA clinical status of affected individuals.
Trial registration
Brazilian Registry of Clinical Trials (ReBEC) protocol #RBR-8g2bc8 (http://www.ensaiosclinicos.gov.br/rg/RBR-8g2bc8/).
Similar content being viewed by others
References
Hajishengallis G (2015) Periodontitis: from microbial immune subversion to systemic inflammation. Nat Rev Immunol 15:30–44. https://doi.org/10.1038/nri3785
Figueredo CM, Alves JC, Beiler TFCSB, Fischer RG (2019) Anti-apoptotic traits in gingival tissue from patients with severe generalized chronic periodontitis. J Investig Clin Dent:e12422. https://doi.org/10.1111/jicd.12422
Firestein GS (2003) Evolving concepts of rheumatoid arthritis. Nature 423:356–361
Li S, Schmalz G, Schmidt J, Krause F, Haak R, Ziebolz D (2018) Antimicrobial peptides as a possible interlink between periodontal diseases and its risk factors: a systematic review. J Periodontal Res 53:145–155
Kinane DF, Preshaw PM, Loos BG, Working Group 2 of Seventh European Workshop on Periodontology (2011) Host-response: understanding the cellular and molecular mechanisms of host-microbial interactions--consensus of the Seventh European Workshop on Periodontology. J Clin Periodontol 38(S-11):44–48. https://doi.org/10.1111/j.1600-051X.2010.01682.x
Yuce HB, Gokturk O, Turkal HA, Inanir A, Benli I, Demir O (2017) Assessment of local and systemic 25-hydroxy-vitamin D, RANKL, OPG, and TNF levels in patients with rheumatoid arthritis and periodontitis. J Oral Sci 59:397–404
Culshaw S, McInnes IB, Liew FY (2011) What can the periodontal community learn from the pathophysiology of rheumatoid arthritis? J Clin Periodontol 38:S106–S113. https://doi.org/10.1111/j.1600-051X.2010.01669.x
Genco RJ, Sanz M (2020) Clinical and public health implications of periodontal and systemic diseases: an overview. Periodontol 83:7–13. https://doi.org/10.1111/prd.12344
Ochanji AA, Matu NK, Mulli TK (2017) Association of salivary RANKL and osteoprotegerin levels with periodontal health. Clin Exp Dent Res 3:45–50. https://doi.org/10.1002/cre2.49
Yan K, Lin Q, Tang K et al (2020) Substance P participates in periodontitis by upregulating HIF-1α and RANKL/OPG ratio. BMC Oral Health 20:27. https://doi.org/10.1186/s12903-020-1017-9
Romas E, Gillespie MT, Martin TJ (2002) Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis. Bone 30:340–346
Danks L, Komatsu N, Guerrini MM, Guerrini MM, Sawa S, Armaka M, Kollias G, Nakashima T, Takayanagi H (2015) RANKL expressed on synovial fibroblasts is primarily responsible for bone erosions during joint inflammation. Ann Rheum Dis 75:1187–1195. https://doi.org/10.1136/annrheumdis-2014-207137
Belibasakis GN, Bostanci N (2012) The RANKL-OPG system in clinical periodontology. J Clin Periodontol 39:239–248. https://doi.org/10.1111/j.1600-051X.2011.01810.x
Baltacıoğlu E, Kehribar MA, Yuva P, Alver A, Atagün ÖS, Karabulut E, Akalın FA (2014) Total oxidant status and bone resorption biomarkers in serum and gingival crevicular fluid of patients with periodontitis. J Periodontol 85:317–326. https://doi.org/10.1902/jop.2013.130012
Gravina G, Wasén C, Garcia-Bonete MJ, Turkkila M, Erlandsson MC, Töyrä Silfverswärd S, Brisslert M, Pullerits R, Andersson KM, Katona G, Bokarewa MI (2017) Survivin in autoimmune diseases. Autoimmun Rev 16:845–855. https://doi.org/10.1016/j.autrev.2017.05.016
Ambrosini G, Adida C, Altieri DC (1997) A novel anti-apoptosis gene, Survivin, expressed in cancer and lymphoma. Nat Med 8:917–921. https://doi.org/10.1038/nm0897-917
Bokarewa M, Lindblad S, Bokarew D, Tarkowski A (2005) Balance between Survivin, a key member of the apoptosis inhibitor family, and its specific antibodies determines erosivity in rheumatoid arthritis. Arthritis Res Ther 7:R349–R358
Svensson B, Hafstrom I, Erlandsson MC, Forslind K, Bokarewa MI (2014) Smoking in combination with antibodies to cyclic citrullinated peptides is associated with persistently high levels of Survivin in early rheumatoid arthritis: a prospective cohort study. Arthritis Res Ther 16:R12
Khodashahi M, Saadati N, Sahebari M, Rezaieyazdi Z, Rastgou N (2020) Diagnostic role of Survivin in rheumatoid arthritis: a systematic review. Curr Rheumatol Rev 15:267–279. https://doi.org/10.2174/1573397116666200116095039
Lucas H, Bartold PM, Dharmapatni AASSK, Holding CA, Haynes DR (2010) Inhibition of apoptosis in periodontitis. J Dent Res 89:29–33. https://doi.org/10.1177/0022034509350708
Johnson RB, Wikle JC (2014) Sex differences in inflammatory and apoptotic signaling molecules in normal and diseased human gingiva. J Periodontol 85:1612–1619. https://doi.org/10.1902/jop.2014.130718
Zhao R, Gu C, Zhang Q, Zhou W, Feng G, Feng X, Dong C, Gu Z (2019) Periodontal disease in Chinese patients with rheumatoid arthritis: a case-control study. Oral Dis 25:2003–2009. https://doi.org/10.1111/odi.13176
Browne RW, Kantarci A, LaMonte MJ et al (2013) Performance of multiplex cytokine assays in serum and saliva among community-dwelling postmenopausal women. PLoS One 8:e59498. https://doi.org/10.1371/journal.pone.0059498
Lahdentausta LSJ, Paju S, Mäntylä P et al (2018) Saliva and serum biomarkers in periodontitis and coronary artery disease. J Clin Periodontol 45:1045–1055. https://doi.org/10.1111/jcpe.12976
Biyikoglu B, Buduneli N, Aksu K, Nalbantsoy A, Lappin DF, Evrenosoglu E, Kinane DF (2013) Periodontal therapy in chronic periodontitis lowers gingival crevicular fluid interleukin-1beta and DAS28 in rheumatoid arthritis patients. Rheumatol Int 33:2607–2616
Cosgarea R, Tristiu R, Dumitru RB, Arweiler NB, Rednic S, Sirbu CI, Lascu L, Sculean A, Eick S (2019) Effects of non-surgical periodontal therapy on periodontal laboratory and clinical data as well as on disease activity in patients with rheumatoid arthritis. Clin Oral Investig 23:141–151. https://doi.org/10.1007/s00784-018-2420-3
Prevoo ML, van’t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–48
Nesse W, Abbas F, van der Ploeg I, Spijkervet FKL, Dijkstra PU, Vissink A (2008) Periodontal inflamed surface area: quantifying inflammatory burden. J Clin Periodontol 35:668–673. https://doi.org/10.1111/j.1600-051X.2008.01249.x
Hujoel PP, White BA, García RI, Listgarten MA (2001) The dentogingival epithelial surface area revisited. J Periodontal Res 36:48–55
Tonetti MS, Greenwell H, Kornman KS (2018) Staging and grading of periodontitis: framework and proposal of a new classification and case definition. J Periodontol 89:S159–S172
Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JMW, Hobbs K, Huizinga TWJ, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, Ménard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, Tak PP, Upchurch KS, Vencovský J, Wolfe F, Hawker G (2010) Rheumatoid arthritis classification criteria: an American College of Rheumatology/European league against rheumatism collaborative initiative. Arthritis Rheum 62:2569–2581. https://doi.org/10.1002/art.27584.2010
Quirynen M, Mongardini C, De Soete M et al (2000) The role of chlorhexidine in the treatment of patients with advanced adult periodontitis. J Clin Periodontol 27:578–589
Khurshid Z, Zohaib S, Najeeb S, Zafar MS, Slowey PD, Almas K (2016) Human saliva collection devices for proteomics: an update. Int J Mol Sci 17:846
Nesse W, Westra J, van der Wal JE et al (2012) The periodontium of periodontitis patients contains citrullinated proteins which may play a role in ACPA (anti-citrullinated protein antibody) formation. J Clin Periodontol 39:599–607. https://doi.org/10.1111/j.1600-051X.2012.01885.x
Reichert S, Schlumberger W, Dähnrich C, Hornig N, Altermann W, Schaller HG, Schulz S (2015) Association of levels of antibodies against citrullinated cyclic peptides and citrullinated α-enolase in chronic and aggressive periodontitis as a risk factor of rheumatoid arthritis: a case control study. J Transl Med 13:283
Schmickler J, Rupprecht A, Patschan S, Patschan D, Müller GA, Haak R, Mausberg RF, Schmalz G, Kottmann T, Ziebolz D (2017) Cross-sectional evaluation of periodontal status, microbiological and rheumatoid parameters in a large cohort of patients with rheumatoid arthritis. J Periodontol 88:368–379. https://doi.org/10.1902/jop.2016.160355
Cheah CW, Al-Maleki AR, Vadivelu J et al (2020) Salivary and serum cathelicidin LL-37 levels in subjects with rheumatoid arthritis and chronic periodontitis. Int J Rheum Dis 00:1–9. https://doi.org/10.1111/1756-185X.13919
Pockpa AD, Soueidan A, Louis P, Coulibaly NT, Badran Z, Struillou X (2018) Twenty years of full-mouth disinfection: the past, the present and the future. Open Dent J 31:435–442. https://doi.org/10.2174/1874210601812010435
Lappin DF, Apatzidou D, Quirke A-M, Oliver-Bell J, Butcher JP, Kinane DF, Riggio MP, Venables P, McInnes IB, Culshaw S (2013) Influence of periodontal disease, Porphyromonas gingivalis and cigarette smoking on systemic anti-citrullinated peptide antibody titres. J Clin Periodontol 40:907–915. https://doi.org/10.1111/jcpe.12138
Khare N, Vanza B, Sagar D, Saurav K, Chauhan R, Mishra S (2016) Nonsurgical periodontal therapy decreases the severity of rheumatoid arthritis: a case-control study. J Contemp Dent Pract 17:484–488
Hussain SB, Botelho J, Machado V, Zehra SA, Mendes JJ, Ciurtin C, Orlandi M, D’Aiuto F (2020) Is there a bidirectional association between rheumatoid arthritis and periodontitis? A systematic review and meta-analysis. Semin Arthritis Rheum 50:414–422. https://doi.org/10.1016/j.semarthrit.2020.01.009
Loutan L, Alpizar-Rodriguez D, Courvoisier DS, Finckh A, Mombelli A, Giannopoulou C (2019) Periodontal status correlates with anti-citrullinated protein antibodies in first-degree relatives of individuals with rheumatoid arthritis. J Clin Periodontol 46:690–698. https://doi.org/10.1111/jcpe.13117
Routsias JG, Goules JD, Goules A, Charalampakis G, Pikazis D (2011) Autopathogenic correlation of periodontitis and rheumatoid arthritis. Rheumatol 50:1189–1193. https://doi.org/10.1093/rheumatology/ker090
Urnowey S, Ansai T, Bitko V, Nakayama K, Takehara T, Barik S (2006) Temporal activation of anti- and pro-apoptotic factors in human gingival fibroblasts infected with the periodontal pathogen, Porphyromonas gingivalis: potential role of bacterial proteases in host signalling. BMC Microbiol 8:6–6. https://doi.org/10.1186/s12866-019-1608-2
Gamonal J, Bascones A, Acevedo A, Blanco E, Silva A (2001) Apoptosis in chronic adult periodontitis analyzed byin situDNA breaks, electron microscopy, and immunohistochemistry. J Periodontol 72:517–525. https://doi.org/10.1902/jop.2001.72.4.517
Bradley EW, Ruan MM, Oursler MJ (2008) PAK1 is a novel MEK-independent raf target controlling expression of the IAP Survivin in M-CSF-mediated osteoclast survival. J Cell Physiol 217:752–758. https://doi.org/10.1002/jcp.21550
Dharmapatni AA, Smith MD, Findlay DM et al (2009) Elevated expression of caspase-3 inhibitors, Survivin and xIAP correlates with low levels of apoptosis in active rheumatoid synovium. Arthritis Res Ther 11:R13
Behfarnia P, Saied-Moallemi Z, Javanmard SH, Naseri R (2016) Serum, saliva, and GCF concentration of RANKL and osteoprotegerin in smokers versus nonsmokers with chronic periodontitis. Adv Biomed Res 5:80. https://doi.org/10.4103/2277-9175.180992
Funding
This study was supported by grants from the National Council of Scientific and Technological Development – CNPq, Brasília, Brazil (Productivity research grant #402158/2016-4).
Author information
Authors and Affiliations
Contributions
All authors have made substantial contributions to the conception and design of the study. MFM, TAS, SRO, FQC, JRC, and FOC have been involved in data collection and data analysis. MFM, TAS, SRO, FQC, GAF, LOMC, SCC, JRC, and FOC have been involved in data interpretation, drafting the manuscript and critically revising it, having given their final approval on the version to be published.
Corresponding author
Ethics declarations
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Conflict of interest
The authors declare no competing interests.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Moura, M.F., Silva, T.A., Cota, L.O.M. et al. Nonsurgical periodontal therapy decreases the severity of rheumatoid arthritis and the plasmatic and salivary levels of RANKL and Survivin: a short-term clinical study. Clin Oral Invest 25, 6643–6652 (2021). https://doi.org/10.1007/s00784-021-03950-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00784-021-03950-4